My Lords, I express my gratitude to the noble Lords, Lord Hunt and Lord Fox, and the noble Baroness, Lady Hayman, for their insightful contributions in this brief debate—not least on the threat from China and on ethical procurement. It has been a pleasure to work with them all and to set the slightly troublesome record of tabling a very large amendments in this House.
I of course acknowledge the importance of tackling the abhorrent practice of organ harvesting, but this amendment is duplicative, unduly burdensome and not appropriately suited to its intended purpose, which is why the Bill has been returned to our House in this form. For these reasons, I do not think that the amendment is necessary and I reiterate the many commitments we have made in this House and in the other place.
The noble Lord, Lord Fox, mentioned the NHS. The Bill applies to NHS bodies and their procurement of goods and services, which are not classed as healthcare services under the provider selection regime. I am pleased to tell the noble Lord, as I hope he knows, that the underpinning regulations were laid by the Department of Health and Social Care on 19 October, which puts a line under that and ensures a consistent approach.
The noble Lord, Lord Fox, remarked on the definition of sensitive sites. Both our Written Ministerial Statement from November last year, which was trailblazing to some extent, and the definition of sensitive sites that I set out only last month make our position on the issue clear to all concerned. We will be sharing annual reports on the removal of surveillance equipment, as I promised the House when we last debated this on 11 September.